AN extensive series of fact sheets are available for list see below of parent fact sheets on newborn screening from STAR-G

AMINO ACID DISORDERS

• Argininemia/arginase deficiency
• ASAL (argininosuccinyl-CoA lyase deficiency)
• ASAS (citrullinemia/Argininosuccinate synthetase deficiency)
• CBS (homocystinemia/cystathionine beta-synthase deficiency)
• MSUD (maple syrup urine disease)
• PKU (phenylketonuria)
• Tyrosinemia

FATTY ACID OXIDATION DISORDERS

• Carnitine transporter deficiency
• CAT (carnitine/acylcarnitine translocase deficiency)
• CPT-1 (carnitine palmitoyl transferase deficiency-type 1)
• CPT-2 (carnitine palmitoyl transferase deficiency-type 2)
• GA-2 (glutaric acidemia-type 2)
• LCHADD (long chain 3-hydroxyacyl-CoA dehydrogenase deficiency)
• MCADD (medium chain acyl-CoA dehydrogenase deficiency)
• SCADD (short chain acyl-CoA dehydrogenase deficiency)
• SCHADD (short chain 3-hydroxyacyl-CoA dehydrogenase deficiency)
• TFP (trifunctional protein deficiency)
• VLCADD (very long chain acyl-CoA dehydrogenase deficiency)

ORGANIC ACID DISORDERS

• BKD (beta-ketothiolase deficiency)
• GA-1 (glutaric acidemia type-1)
• GA-2 (glutaric acidemia type-2)
• HCSD (holocarboxylase synthetase deficiency)
• HMGCoA (3-hydroxy-3-methylglutaryl-CoA lyase deficiency)
• Isobutyryl-CoA dehydrogenase deficiency
• IVA (isovaleric acidemia)
• MMA (methylmalonic acidemia)
• MMA+HCU (Methylmalonic Acidemia with Homocystinuria)
• PA (propionic acidemia)
• 3MCC (3-methylcrotonyl-CoA carboxylase deficiency)
• 2MBC (2-methylbutyryl-CoA dehydrogenase deficiency)

OTHER DISORDERS

• CAH (Congenital Adrenal Hyperplasia)
• CH (Congenital Hypothyroidism)
• CF (Cystic Fibrosis)
• Galactosemia (GALT deficiency)
• Alpha Thalassemia
• Sickle Cell Disease

ABOUT STAR-G

The Screening, Technology And Research in Genetics (STAR-G) Project began as a multi-state collaborative effort, led by the Hawai`i Department of Health, to obtain research data, identify strategies and develop materials for addressing the financial, ethical, legal and social issues (FELSI) surrounding the use of MS/MS for neonatal metabolic screening of culturally and ethnically diverse populations. The project was funded by the Health Resources and Services Administration (HRSA) through a Special Projects of Regional and National Significance (SPRANS) grant

Who are STAR-G go to